Group 1: Company Overview - Jiangxi Fushite Hydraulic Co., Ltd. specializes in the research, production, and sales of hydraulic pipeline systems, with key products including hard pipe assemblies, soft pipe assemblies, fire extinguishing systems, pipe joints, and oil tanks [3][4] - The hydraulic pipeline is essential for various machinery manufacturing industries, including construction machinery, mining machinery, port machinery, agricultural machinery, logistics, metallurgy, and wind power equipment [3][4] - The company has established a strong customer base, including leading enterprises such as SANY, Zoomlion, Jiangxi Copper, State Power Investment Corporation, and Schwing [3][4] Group 2: Market Segmentation - The company's product applications are divided into two main categories: the front-mounted market and the post-mining maintenance market [3][4] - The front-mounted market has seen growth due to the recovery of the construction machinery market and accelerated overseas exports [4][5] - The post-mining maintenance market is expected to expand significantly as the company has a first-mover advantage and a stable service network established in major domestic mines [4][7] Group 3: Future Development Plans - The company aims to focus on two major markets: the front-mounted market and the post-mining maintenance market, with plans to explore new fields such as semiconductor equipment pipelines and liquid cooling [5][6] - International mining markets are a key focus, with ongoing efforts to expand overseas service points in countries like Suriname, Serbia, Mongolia, and Namibia [4][5][10] - The company is transitioning from pipeline system maintenance to comprehensive lifecycle monitoring and management of mining equipment [5][6] Group 4: Competitive Advantages - The company has over 20 years of experience in the post-mining maintenance market, establishing stable partnerships with major clients [7] - Continuous growth in fixed asset investment in the mining industry is driving demand for maintenance and repair services [7] - The company has built a high-quality technical team that supports its maintenance services, enhancing its reputation and customer relationships [7] Group 5: Strategic Collaborations - The strategic cooperation with Jiangxi Copper focuses on equipment maintenance, lifecycle monitoring, and overseas market expansion [8] - The company has partnered with large mining enterprises like Zijin Mining and China General Nuclear Power Corporation to enhance its international business [10] Group 6: Financial and Operational Insights - The revenue from the front-mounted market currently exceeds that of the post-mining maintenance market, but the latter is expected to grow as overseas markets expand [6] - The company has begun production in its high-strength welded pipe segment, with capacity gradually being released and revenue generation underway [10] - Increased management expenses are attributed to intensified market development efforts and personnel expansion [10]

证券代码：000758 证券简称：中色股份 中国有色金属建设股份有限公司 4. 秘鲁 Raura 项目情况如何？ 秘鲁 Raura 项目为在产锌多金属矿山，采选规模 100 万吨/ 年，主要产品为锌精矿、铅精矿、铜精矿，银金属主要富集在铅 精矿和铜精矿中。项目保有资源量为：锌金属 161.37 万吨，铅 金属 34.78 万吨，银金属 1,872 吨，铜金属 11.92 万吨，目前资 源储量及采矿作业仅针对其中一宗在产矿权，其余矿权地质工作 将在完成收购后有序开展。2024 年，Raura 项目处理矿石量 102.48 万吨，锌入选品位 5.51%，铅入选品位 1.19%，银入选品位 1.84 盎司每吨，铜入选品位 0.25%。2026 年，公司将积极推进项目交 割，确保生产经营平稳过渡、有序衔接。 5. 中色白矿扩产的情况如何？ 2025 年，中色白矿成功取得 165 万吨/年采矿证，经公司董 事会审议，中色白矿拟投资 17.4 亿元建设 165 万吨/年铅锌矿采 选扩建项目，新建主井、辅助斜坡道、5000t/d 选厂、尾矿库及 尾矿输送泵站及相应辅助设施等，同时进行自动化水平及生产装 备改造升级，项目建设 ...

Company Overview - Proris is a data-driven clinical research service provider focused on patient-centered clinical trials, aiming to enhance the efficiency and compliance of clinical trial management for innovative drug development [1][2] - Since its establishment, Proris has undertaken over 4,200 SMO projects, with 2,538 currently active, and has a workforce of 4,271 employees [2] - The company has served over 960 clinical trial institutions across more than 200 cities in China, benefiting over 420,000 participants and assisting in the approval of over 210 new drugs [2] Financial Performance - Proris has distributed a total of CNY 46.1455 million in cash dividends since its listing, reflecting a commitment to shareholder returns [2] Industry Demand - In 2025, the number of drug clinical trials in China reached 5,173, a year-on-year increase of 6.44%, with 76 innovative drugs approved, marking a 58% increase [3] - China holds approximately 30% of the global new drug pipeline, ranking second worldwide, indicating a vibrant landscape for innovative drug development [3] Market Trends - The total value of innovative drug licensing transactions in China exceeded USD 130 billion in 2025, with over 150 transactions, setting a historical record [3] - The SMO industry is experiencing a trend towards consolidation, with leading firms expanding their client resources and operational capabilities, while smaller firms are gradually exiting the market [4] Client Base - Proris primarily serves multinational pharmaceutical companies, domestic innovative drug firms, and CROs, collaborating with all of the top 10 global pharmaceutical companies as of 2024 [5] Digital Transformation - The company emphasizes the development and application of digital and intelligent technologies as a key strategic focus, aiming to enhance project execution efficiency through a collaborative clinical trial management platform [6] Quality Management - Proris has established a comprehensive quality management system, having undergone 281 inspections by national and provincial authorities, as well as 14 FDA and 5 EMA inspections, with no major findings reported [7][9] - The company maintains over 280 standard operating procedures (SOPs) to ensure compliance and quality in its operations [9]

Group 1: Company Overview and Strategy - The company is actively involved in the research and development of valves for nuclear fusion applications, with a focus on high-quality products [3] - The company has established a comprehensive product matrix that includes nuclear-grade butterfly valves, ball valves, and other critical components [5] - The goal is to enhance the value of each unit to over 100 million yuan, driven by product line expansion and increased spare parts market [8] Group 2: Product Development and Market Engagement - The company is increasing resource investment to accelerate the development of advanced technologies and expand its high-end valve product range [6] - The subsidiary, Jiangsu Shentong Semiconductor Technology, has successfully validated and introduced vacuum valves and process gas valves into customer production lines [9] - The company has established partnerships in the aerospace sector, supplying components for satellite propulsion systems and achieving small-scale deliveries [10] Group 3: Operational Insights - Despite a design lifespan of 60 years for nuclear valves, regular maintenance and replacement of key components are necessary due to harsh operational conditions [7] - The company exports nuclear valve products primarily through indirect channels, partnering with large domestic enterprises for overseas projects [4] Group 4: Investor Relations - The investor meeting was held on February 5, 2026, with a total of 10 attendees, emphasizing compliance with disclosure regulations [2] - The meeting concluded without any significant undisclosed information being leaked [12]

Group 1: Investor Relations Activity - The investor relations activity included a site visit on February 5, 2026 [2] - Participating institutions were Guosen Securities, Hu'an Securities, Western Securities, Wanbo Investment, and Banxia Investment [2] - The meeting was held in the company conference room, hosted by Vice President and Board Secretary Mr. Zhang Qiqiang [2] Group 2: Discussion Topics - Institutional investors discussed the company's production and operational status, future development plans, and strategies [2] - The meeting aimed to facilitate communication between the company and institutional investors regarding its business outlook [2] - The detailed content of the discussions is available in the attachment: Investor Research Meeting Record dated February 5, 2026 [2]

Group 1: Event Overview - The investor relations activity took place from January 5 to February 6, 2026, at the New Industry Biomedical Building in Shenzhen [2] - A total of 25 institutions and 30 participants attended the event [2] Group 2: Participants and Representatives - Key representatives from the company included Chairman and General Manager Rao Wei, Deputy General Manager and Board Secretary Zhang Lei, and Investor Relations Head Lv Yuning [2] - The list of participating institutions includes notable names such as HSBC Global Asset Management, Morgan Stanley Investment Management, and several domestic fund management companies [4] Group 3: Content of the Meeting - The main content of the investor relations activity did not introduce any new major interactive communication beyond previously disclosed information [2]

Group 1: Business Overview - Guanghong Holdings has a current pig farming capacity of nearly 700,000 heads, covering regions such as Huizhou, Xingning, Haifeng, and Jiangmen, forming a "core breeding + standard expansion" industrial chain [3] - The company has adopted a light asset model through leasing and cooperative operations to rapidly enhance production capacity, resulting in improved survival rates and cost control in the breeding process [3] - The market potential for the company's pig farming business is gradually being released, driven by high-end pork demand in the Guangdong-Hong Kong-Macao Greater Bay Area [3] Group 2: Poultry Breeding - The poultry breeding segment focuses on source innovation, capacity and base layout, full industry chain collaboration, and a light asset model, establishing a differentiated advantage in the poultry market of the Guangdong-Hong Kong-Macao Greater Bay Area [3] - The company has developed the "Guanghong No. 3" white-feather chicken, which has a lower feed conversion ratio compared to similar breeds, potentially saving 51,000 tons of feed annually if 200 million chickens are promoted each year [3] - The breeding process utilizes advanced genetic detection technologies, achieving over 200 million breeding data processing, enhancing the purity of the breed and ensuring strong market competitiveness [3] Group 3: Cold Chain Distribution - Guanghong Holdings has established a cold chain food distribution system with a capacity of 80,000 tons of cold storage and an annual throughput of nearly 1 million tons, providing comprehensive services in storage, trading, distribution, testing, and traceability [4] - The company has implemented a campus meal distribution model in Xinyi City, serving over 90,000 teachers and students, creating a replicable "Xinyi model" for expanding corporate meal services and increasing the share of self-owned products in meal distribution [4]

Group 1: Company Overview - Zhejiang Rifa Precision Machinery Co., Ltd. is a leading supplier in the bearing manufacturing equipment sector, with a strong market share in China [3] - The company has developed a comprehensive solution provider for cold processing, covering various product lines including CNC grinding machines and assembly lines [3] Group 2: Product Offerings - Rifa's product range includes seven major series such as bearing grinding automatic lines, CNC thread grinders, and CNC lathes, catering to diverse industries including automotive and aerospace [3][4] - The CNC thread grinding equipment is designed for high-precision applications in sectors like new energy vehicles and industrial automation, with ongoing market expansion [4] Group 3: Development Plans - The company aims to focus on R&D, improve product details, and enhance production efficiency to create high-precision and intelligent products [4] - Future development will prioritize tracking technological advancements in downstream clients and enhancing product development in relevant fields [4] Group 4: Strategic Decisions - The sale of the stake in Italian company MCM is part of a strategic move to optimize asset structure and concentrate resources on core business areas [4][5] - This strategic decision is expected to support the company's long-term development and align with its strategic planning [5]

答：公司一是着力打造"支付+结算+财税合规+增值服务"的全方位产品与服务 体系，旨在打造金融科技与数据赋能的生态圈，除了为客户提供高效便捷的支付结 算业务外，更为企业客户创造更多附加价值；二是大力发展数字人民币支付相关业 务。利用公司在数字人民币业务领域的先发优势，积极打造数字人民币支付和应用 场景；三是子公司中金支付，作为广州首家拥有支付牌照已具备跨境人民币支付资 质，聚焦进出口电商等交易主体，推出了相应的支付结算产品与服务。此外，公司 全资子公司汇通香港获得了香港 MSO 牌照，接下来会连同中金支付在牌照、客户资 源，支付结算解决方案等多方面联动，搭起"境内+境外"的一体化资金通道。近期, 公司发布了"汇晶盈"财税合规资金管理解决方案与"广汇通 GPX"全球收款产品， 以智慧支付技术助力企业应对国内电商财税合规与跨境出海资金管理。目前公司支 付业务板块形成了全牌照资质与"境内外双持牌"布局，未来随着"支付+金融科技 +生态服务"模式不断成熟，公司将致力于为境内外电商、跨境贸易、供应链等行业 提供合规、智能、全球化的支付与资金管理解决方案，推动"支付+科技+场景"深 度融合。 4、数字人民币方面，请介绍下公 ...

编号：2026-004 | 投资者关系活动类 | √ 特定对象调研 □ 分析师会议 | | --- | --- | | 别 | □ 媒体采访 □ 业绩说明会 | | | 新闻发布会 路演活动 □ □ | | | □ 现场参观 | | | □ 其他 （请文字说明其他活动内容） | | 活动参与人员 | 东吴证券 黄诗涛 信达澳银基金 李琳娜 王天乐 | | 时间 | 2026 年 2 月 6 日 | | 地点 | 箭牌总部大厦 | | 形式 | 线上电话会议 | | 公司接待人员 | 副总经理、董事会秘书 杨伟华 | | | 1、公司经营策略调整情况 | | | 2025 年，基于对公司整体经营情况的复盘，并紧密围绕市场 | | | 变化，确立了以零售渠道建设为核心，深耕零售渠道的精细化运 | | | 营管理，以店效倍增项目为抓手，向经销商持续赋能，重点驱动 | | | 零售渠道的增长。前三季度，店效倍增项目分阶段稳步推进，经 | | | 销商试点门店店效实现显著提升，有效带动了公司经销零售收入 | | | 的增长。同时，公司在产品端积极发力，发布鸿蒙智选箭牌智能 | | | 花洒等产品，为后续发展奠定了基础。 ...